Centrexion Therapeutics (Centrexion Therapeutics) Interest Coverage : N/A (As of Sep. 2018)

View and export this data going back to 2018. Start your Free Trial

What is Centrexion Therapeutics Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Centrexion Therapeutics's Operating Income for the three months ended in Sep. 2018 was $0.00 Mil. Centrexion Therapeutics's Interest Expense for the three months ended in Sep. 2018 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Centrexion Therapeutics's Interest Coverage or its related term are showing as below:

CNTX's Interest Coverage is not ranked ^*
in the industry.
Industry Median:
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Centrexion Therapeutics Interest Coverage Historical Data

The historical data trend for Centrexion Therapeutics's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Centrexion Therapeutics Interest Coverage Chart

Centrexion Therapeutics Annual Data

Trend

Dec16

Dec17

Interest Coverage

Centrexion Therapeutics Quarterly Data
	Dec16	Dec17	Sep18
Interest Coverage	N/A	-	N/A

Competitive Comparison of Centrexion Therapeutics's Interest Coverage

For the subindustry, Centrexion Therapeutics's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centrexion Therapeutics's Interest Coverage Distribution in the Industry

For the industry and sector, Centrexion Therapeutics's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Centrexion Therapeutics's Interest Coverage falls into.

Centrexion Therapeutics Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Centrexion Therapeutics's Interest Coverage for the fiscal year that ended in Dec. 2017 is calculated as

Here, for the fiscal year that ended in Dec. 2017, Centrexion Therapeutics's Interest Expense was $-0.98 Mil. Its Operating Income was $-24.06 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.39 Mil.

Centrexion Therapeutics did not have earnings to cover the interest expense.

Centrexion Therapeutics's Interest Coverage for the quarter that ended in Sep. 2018 is calculated as

Here, for the three months ended in Sep. 2018, Centrexion Therapeutics's Interest Expense was $0.00 Mil. Its Operating Income was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was $6.71 Mil.

GuruFocus does not calculate Centrexion Therapeutics's interest coverage with the available data.

The higher the ratio, the stronger the company's Financial Strength is.

Centrexion Therapeutics (NAS:CNTX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Centrexion Therapeutics Interest Coverage Related Terms

Thank you for viewing the detailed overview of Centrexion Therapeutics's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.